{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:30:45Z","timestamp":1793125845219,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The China International Medical Foundation SKY Imaging Research Fund","award":["No. Z-2014-07-2101"],"award-info":[{"award-number":["No. Z-2014-07-2101"]}]},{"name":"Clinical Medical Technology Innovation Guiding Project of Hunan Province","award":["2021SK50911"],"award-info":[{"award-number":["2021SK50911"]}]},{"name":"Scientific Research Project of Hunan Health Commission in 2022","award":["No. 202209010030"],"award-info":[{"award-number":["No. 202209010030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14397-y","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T08:41:36Z","timestamp":1754469696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development and validation of a CT-measured body composition radiomics model for prognostic assessment in resected pancreatic adenocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Qianbiao","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"14397_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L. et al. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"14397_CR2","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.3390\/curroncol30040282","volume":"30","author":"G Nappo","year":"2023","unstructured":"Nappo, G. et al. Early recurrence after upfront surgery for pancreatic ductal adenocarcinoma. Curr. Oncol. 30, 3708\u20133720 (2023).","journal-title":"Curr. Oncol."},{"key":"14397_CR3","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.surg.2022.11.015","volume":"173","author":"G Malleo","year":"2023","unstructured":"Malleo, G. et al. A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma. Surgery 173, 1030\u20131038 (2023).","journal-title":"Surgery"},{"key":"14397_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.surg.2018.04.017","volume":"164","author":"SH Shin","year":"2018","unstructured":"Shin, S. H. et al. Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: a single-center experience with 2,029 patients. Surgery 164, 432\u2013442 (2018).","journal-title":"Surgery"},{"key":"14397_CR5","doi-asserted-by":"publisher","first-page":"651671","DOI":"10.3389\/fonc.2021.651671","volume":"11","author":"X Shi","year":"2021","unstructured":"Shi, X. et al. Impact of adjuvant chemoradiotherapy on survival of resected pancreatic adenocarcinoma cancer: A surveillance, epidemiology and end results (SEER) analysis. Front. Oncol. 11, 651671 (2021).","journal-title":"Front. Oncol."},{"key":"14397_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.hpb.2022.10.004","volume":"25","author":"H Suto","year":"2023","unstructured":"Suto, H. et al. Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinoma. HPB (Oxford). 25, 136\u2013145 (2023).","journal-title":"HPB (Oxford)"},{"key":"14397_CR7","unstructured":"National Comprehensive Cancer Network. Pancreatic Adenocarcinoma, Version 1. NCCN Clinical Practice Guidelines in Oncology. Web site. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1455 (2023)."},{"key":"14397_CR8","doi-asserted-by":"publisher","first-page":"e183617","DOI":"10.1001\/jamasurg.2018.3617","volume":"153","author":"S van Roessel","year":"2018","unstructured":"van Roessel, S. et al. International validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer. JAMA Surg. 153, e183617 (2018).","journal-title":"JAMA Surg."},{"key":"14397_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.hbpd.2022.09.009","volume":"22","author":"S Xu","year":"2023","unstructured":"Xu, S. et al. Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma. Hepatobiliary Pancreat. Dis. Int. 22, 160\u2013168 (2023).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"14397_CR10","first-page":"undefined","volume":"10","author":"SJ Yoon","year":"2023","unstructured":"Yoon, S. J. et al. Development of nomograms for predicting prognosis of pancreatic cancer after pancreatectomy: A multicenter study. Biomedicines 10, undefined (2023).","journal-title":"Biomedicines"},{"key":"14397_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00330-023-09980-8","volume":"34","author":"D Li","year":"2024","unstructured":"Li, D. et al. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9. Eur. Radiol. 34, 509\u2013524 (2024).","journal-title":"Eur. Radiol."},{"key":"14397_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.21037\/hbsn-21-99","volume":"11","author":"GR Joliat","year":"2022","unstructured":"Joliat, G. R. et al. International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma. Hepatobiliary Surg. Nutr. 11, 822\u2013833 (2022).","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"14397_CR13","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3390\/curroncol29040206","volume":"29","author":"DL Hughes","year":"2022","unstructured":"Hughes, D. L. et al. Predicting early disease recurrence of pancreatic cancer following surgery: determining the role of NUDT15 as a prognostic biomarker. Curr. Oncol. 29, 2516\u20132529 (2022).","journal-title":"Curr. Oncol."},{"key":"14397_CR14","doi-asserted-by":"publisher","first-page":"1074445","DOI":"10.3389\/fonc.2023.1074445","volume":"13","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma. Front. Oncol. 13, 1074445 (2023).","journal-title":"Front. Oncol."},{"key":"14397_CR15","first-page":"2032","volume":"12","author":"H Qiu","year":"2022","unstructured":"Qiu, H. et al. A novel preoperative MRI-based radiomics nomogram outperforms traditional models for prognostic prediction in pancreatic ductal adenocarcinoma. Am. J. Cancer Res. 12, 2032\u20132049 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"14397_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/jmri.27024","volume":"52","author":"TY Tang","year":"2020","unstructured":"Tang, T. Y. et al. Development of a novel multiparametric MRI radiomic nomogram for preoperative evaluation of early recurrence in resectable pancreatic cancer. J. Magn. Reson. Imaging. 52, 231\u2013245 (2020).","journal-title":"J. Magn. Reson. Imaging"},{"key":"14397_CR17","doi-asserted-by":"crossref","unstructured":"Rupert, J. E. et al. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. J. Exp. Med. 218, undefined (2021).","DOI":"10.1084\/jem.20190450"},{"key":"14397_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","volume":"19","author":"C Qin","year":"2020","unstructured":"Qin, C. et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol. Cancer. 19, 50 (2020).","journal-title":"Mol. Cancer"},{"key":"14397_CR19","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3390\/cancers13122921","volume":"13","author":"U Fehrenbach","year":"2021","unstructured":"Fehrenbach, U. et al. CT body composition of sarcopenia and sarcopenic obesity: predictors of postoperative complications and survival in patientswith locally advanced esophageal adenocarcinoma. Cancers 13, 2921 (2021).","journal-title":"Cancers"},{"key":"14397_CR20","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1007\/s00330-020-07294-7","volume":"31","author":"YC Peng","year":"2021","unstructured":"Peng, Y. C. et al. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy. Eur. Radiol. 31, 2472\u20132481 (2021).","journal-title":"Eur. Radiol."},{"key":"14397_CR21","doi-asserted-by":"crossref","unstructured":"Pierobon, E. S. et al. The prognostic value of low muscle mass in pancreatic cancer patients: a systematic review and meta-analysis. J. Clin. Med. 10, undefined (2021).","DOI":"10.3390\/jcm10143033"},{"key":"14397_CR22","doi-asserted-by":"crossref","unstructured":"Beetz, N. L. et al. Influence of baseline CT body composition parameters on survival in patients with pancreatic adenocarcinoma. J. Clin. Med. 11, undefined (2022).","DOI":"10.3390\/jcm11092356"},{"key":"14397_CR23","doi-asserted-by":"publisher","first-page":"10912","DOI":"10.1038\/s41598-022-15120-x","volume":"12","author":"M Sibeijn","year":"2022","unstructured":"Sibeijn, M. & Pequito, S. A time-reversed model selection approach to time series forecasting. Sci. Rep. 12, 10912 (2022).","journal-title":"Sci. Rep."},{"key":"14397_CR24","doi-asserted-by":"crossref","unstructured":"Borrelli, A. et al. Standardization of body composition status in patients with advanced urothelial tumors: The role of a CT-based AI-powered software for the assessment of sarcopenia and patient outcome correlation. Cancers. 15, undefined (2023).","DOI":"10.3390\/cancers15112968"},{"key":"14397_CR25","doi-asserted-by":"crossref","unstructured":"Bradley, N. A. et al. Evaluation of the prognostic value of computed tomography-derived body composition in patients undergoing endovascular aneurysm repair. J. Cachexia Sarcopenia Muscle. undefined, undefined (2023).","DOI":"10.1002\/jcsm.13262"},{"key":"14397_CR26","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s00330-019-06600-2","volume":"30","author":"T Xie","year":"2020","unstructured":"Xie, T. et al. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival Estimation after curative resection. Eur. Radiol. 30, 2513\u20132524 (2020).","journal-title":"Eur. Radiol."},{"key":"14397_CR27","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3348\/kjr.2023.1235","volume":"25","author":"B Jeong","year":"2024","unstructured":"Jeong, B. et al. Predicting recurrence-free survival after upfront surgery in resectable pancreatic ductal adenocarcinoma: A preoperative risk score based on CA 19\u2009\u2013\u20099, CT, and 18F-FDG PET\/CT. Korean J. Radiol. 25, 644\u2013655 (2024).","journal-title":"Korean J. Radiol."},{"key":"14397_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/14737140.2022.2026771","volume":"22","author":"G Capurso","year":"2022","unstructured":"Capurso, G. et al. The impact of nutritional status on pancreatic cancer therapy. Expert Rev. Anticancer Ther. 22, 155\u2013167 (2022).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"14397_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/01635581.2019.1634217","volume":"72","author":"DH Bicakli","year":"2019","unstructured":"Bicakli, D. H. et al. The relationship between nutritional status, performance status, and survival among pancreatic cancer patients. Nutr. Cancer. 72, 202\u2013208 (2019).","journal-title":"Nutr. Cancer"},{"key":"14397_CR30","doi-asserted-by":"crossref","unstructured":"Elhakim, T. et al. Role of machine learning-based CT body composition in risk prediction and prognostication: current state and future directions. Diagnostics. 13, undefined (2023).","DOI":"10.3390\/diagnostics13050968"},{"key":"14397_CR31","doi-asserted-by":"crossref","unstructured":"Nachit, M. et al. AI-based CT body composition identifies myosteatosis as key mortality predictor in asymptomatic adults. Radiology. undefined, 222008 (2023).","DOI":"10.1148\/radiol.222008"},{"key":"14397_CR32","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.3390\/curroncol28060406","volume":"28","author":"A Jachnis","year":"2021","unstructured":"Jachnis, A. & S\u0142odkowski, M. T. The relationship between nutritional status and body composition with clinical parameters, tumor stage, CA19-9, CEA levels in patients with pancreatic and periampullary tumors. Curr. Oncol. 28, 4805\u20134820 (2021).","journal-title":"Curr. Oncol."},{"key":"14397_CR33","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1245\/s10434-017-6077-y","volume":"24","author":"S Okumura","year":"2017","unstructured":"Okumura, S. et al. Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer. Ann. Surg. Oncol. 24, 3732\u20133740 (2017).","journal-title":"Ann. Surg. Oncol."},{"key":"14397_CR34","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1007\/s00259-022-05773-1","volume":"49","author":"G Yang","year":"2022","unstructured":"Yang, G. et al. The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study. Eur. J. Nucl. Med. Mol. Imaging. 49, 2949\u20132959 (2022).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"14397_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcsm.12155","volume":"8","author":"DP van Dijk","year":"2017","unstructured":"van Dijk, D. P. et al. Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer. J. Cachexia Sarcopenia Muscle. 8, 317\u2013326 (2017).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"14397_CR36","doi-asserted-by":"publisher","first-page":"109834","DOI":"10.1016\/j.ejrad.2021.109834","volume":"142","author":"TH Hsu","year":"2021","unstructured":"Hsu, T. H. et al. Artificial intelligence to assess body composition on routine abdominal CT scans and predict mortality in pancreatic cancer- A recipe for your local application. Eur. J. Radiol. 142, 109834 (2021).","journal-title":"Eur. J. Radiol."},{"key":"14397_CR37","doi-asserted-by":"crossref","unstructured":"Guarneri, G. et al. Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer. Eur. J. Surg. Oncol. undefined, undefined (2023).","DOI":"10.1016\/j.hpb.2023.07.180"},{"key":"14397_CR38","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.ultrasmedbio.2020.12.012","volume":"47","author":"MT Paris","year":"2021","unstructured":"Paris, M. T. & Mourtzakis, M. Muscle composition analysis of ultrasound images: A narrative review of texture analysis. Ultrasound Med. Biol. 47, 880\u2013895 (2021).","journal-title":"Ultrasound Med. Biol."},{"key":"14397_CR39","doi-asserted-by":"publisher","first-page":"undefine","DOI":"10.7554\/eLife.23421","volume":"6","author":"P Grossmann","year":"2017","unstructured":"Grossmann, P. et al. Defining the biological basis of radiomic phenotypes in lung cancer. Elife 6, undefine (2017).","journal-title":"Elife"},{"key":"14397_CR40","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins, G. S. et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350, g7594 (2015).","journal-title":"BMJ"},{"key":"14397_CR41","doi-asserted-by":"publisher","first-page":"l737","DOI":"10.1136\/bmj.l737","volume":"365","author":"LJ Bonnett","year":"2019","unstructured":"Bonnett, L. J. et al. Guide to presenting clinical prediction models for use in clinical settings. BMJ 365, l737 (2019).","journal-title":"BMJ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14397-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14397-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14397-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T21:09:32Z","timestamp":1757365772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14397-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14397"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14397-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board. Written informed consent was revoked for this retrospective study. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28722"}}